These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35182548)

  • 1. Blood transcriptome profiling identifies 2 candidate endotypes of atopic dermatitis.
    Möbus L; Rodriguez E; Harder I; Boraczynski N; Szymczak S; Hübenthal M; Stölzl D; Gerdes S; Kleinheinz A; Abraham S; Heratizadeh A; Handrick C; Haufe E; Werfel T; Schmitt J; Weidinger S;
    J Allergy Clin Immunol; 2022 Aug; 150(2):385-395. PubMed ID: 35182548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype.
    Dyjack N; Goleva E; Rios C; Kim BE; Bin L; Taylor P; Bronchick C; Hall CF; Richers BN; Seibold MA; Leung DYM
    J Allergy Clin Immunol; 2018 Apr; 141(4):1298-1309. PubMed ID: 29309794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atopic dermatitis displays stable and dynamic skin transcriptome signatures.
    Möbus L; Rodriguez E; Harder I; Stölzl D; Boraczynski N; Gerdes S; Kleinheinz A; Abraham S; Heratizadeh A; Handrick C; Haufe E; Werfel T; Schmitt J; Weidinger S;
    J Allergy Clin Immunol; 2021 Jan; 147(1):213-223. PubMed ID: 32615169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood mononuclear cell- transcriptome signatures of atopic dermatitis and prediction for the efficacy of dupilumab.
    Wang Y; Wu Y; Gu C; Wang S; Yin H; Zhu R; Wang C; Li Z; Yao X; Li W
    J Dermatol Sci; 2023 Sep; 111(3):83-92. PubMed ID: 37349237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab.
    Wu Y; Gu C; Wang S; Yin H; Qiu Z; Luo Y; Li Z; Wang C; Yao X; Li W
    Br J Dermatol; 2023 Apr; 188(5):649-660. PubMed ID: 36756674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-Seq Identifies Marked Th17 Cell Activation and Altered CFTR Expression in Different Atopic Dermatitis Subtypes in Chinese Han Populations.
    Tian X; Liu B; Chen L; Xie Y; Liang J; Yang Y; Shao L; Zhang J; Wang J; Zhang X; Wu Z; Liu Y
    Front Immunol; 2021; 12():628512. PubMed ID: 33868246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitis.
    Möbus L; Rodriguez E; Harder I; Schwarz A; Wehkamp U; Stölzl D; Boraczynski N; Gerdes S; Litman T; Kleinheinz A; Abraham S; Heratizadeh A; Handrick C; Haufe E; Schmitt J; Werfel T; Weidinger S;
    J Allergy Clin Immunol; 2021 May; 147(5):1959-1965.e2. PubMed ID: 33390269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome-based identification of novel endotypes in adult atopic dermatitis.
    Lefèvre-Utile A; Saichi M; Oláh P; Delord M; Homey B; Soumelis V;
    Allergy; 2022 May; 77(5):1486-1498. PubMed ID: 34689335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of High and Low IFNG-Expressing Subgroups in Atopic Dermatitis.
    Wasserer S; Jargosch M; Mayer KE; Eigemann J; Raunegger T; Aydin G; Eyerich S; Biedermann T; Eyerich K; Lauffer F
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications.
    Suárez-Fariñas M; Ungar B; Correa da Rosa J; Ewald DA; Rozenblit M; Gonzalez J; Xu H; Zheng X; Peng X; Estrada YD; Dillon SR; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 May; 135(5):1218-27. PubMed ID: 25840722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
    Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR
    N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
    Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
    J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
    Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
    Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patients.
    Brunner PM; Israel A; Leonard A; Pavel AB; Kim HJ; Zhang N; Czarnowicki T; Patel K; Murphrey M; Ramsey K; Rangel S; Zebda R; Soundararajan V; Zheng X; Estrada YD; Xu H; Krueger JG; Paller AS; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2019 Mar; 122(3):318-330.e3. PubMed ID: 30508584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma.
    Badi YE; Pavel AB; Pavlidis S; Riley JH; Bates S; Kermani NZ; Knowles R; Kolmert J; Wheelock CE; Worsley S; Uddin M; Alving K; Bakke PS; Behndig A; Caruso M; Chanez P; Fleming LJ; Fowler SJ; Frey U; Howarth P; Horváth I; Krug N; Maitland-van der Zee AH; Montuschi P; Roberts G; Sanak M; Shaw DE; Singer F; Sterk PJ; Djukanovic R; Dahlen SE; Guo YK; Chung KF; Guttman-Yassky E; Adcock IM;
    J Allergy Clin Immunol; 2022 Jan; 149(1):89-101. PubMed ID: 33891981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Do Classical Subtypes Correspond to Endotypes in Atopic Dermatitis?
    Suzuki T; Kondo S; Ogura Y; Otsuka M; Tokura Y
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atopic dermatitis stratification: current and future perspective on skin and blood transcriptomic and proteomic profiling.
    Hawkins K; David E; Glickman JW; Del Duca E; Guttman-Yassky E; Krueger JG
    Expert Rev Clin Immunol; 2024 Sep; 20(9):1083-1088. PubMed ID: 38436065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
    Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
    J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
    Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A
    Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.